China / CanSino’s Inhaled COVID-19 Vaccine Approval; HitGen/Unison’s Anti-Infectives Deal; Neukio Biotherapeutics Funding
China healthcare and life sciences news. Top stories include the NMPA approvals of CanSino’s inhaled COVID-19 vaccine and AstraZeneca’s CKD treatment, HitGen/Unison’s anti-infectives deal and the funding secured by cell…